Angel Forum
VC Fund
Vancouver, Canada
Angel Forum is a VC fund in Vancouver focused on Biotechnology and Health Care. Founded 16 years ago in 1997, it is the only Angel Capital Forum ™ in Canada that introduces emerging companies to private equity Angel Investors. Presenting companies have raised over $35 million directly through the Forum. Read this third party blog comment and video overview. Since 1998, it has offered Investor Ready ™ workshops for companies& investors.As the oldest & largest angel network in Western Canada with 50+ investors (from Vancouver, Calgary, Edmonton, Kelowna, Victoria, Bellingham and Seattle), they are supported by leading organizations in BC and belong to Canada's National Angel Capital Organization and US's Angel Capital Association. Their private meetings are exclusive to only pre-registered Investors, selected Companies and Sponsors. Regretfully no observers except volunteers.
- Total investments:
- 15
- Last investment:
- Lead investor:
- 40%
Last updated:
For AI agents: llms.txt
Industries Angel Forum invests in
Stages Angel Forum invests in
Countries Angel Forum invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $120k–$500k
Investment Focus
Industry
- Biotechnology 4 (27%)
- Health Care 3 (20%)
- Information Technology 3 (20%)
- Farming 2 (13%)
- FinTech 2 (13%)
Stage
- Seed 7 (47%)
- Angel 7 (47%)
- Pre-Seed 1 (7%)
Country
- Canada 13 (87%)
- United States 2 (13%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Bob Chaworth-Musters
Founder & Managing Director
|
Founder & Managing Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Truss
|
Truss is the fastest and easiest way to move money for construction companies, including general contractors, subcontractors, suppliers, and more. With Truss, construction companies can send and receive payments instantly and for free. Collect money from clients via email and use it immediately to pay suppliers or withdraw via card—all from onesimple dashboard. No transfer fees, no hidden costs, and no-nonsense. | $354.3K / Pre-Seed / May 15, 2020 | |
Cuboh
|
Cuboh is a developer of an application intended to automate online food orders for restaurants. The company's platform helps to use several delivery platforms like Doordash, Postmates, UberEats and more by bringing them all to one system and integrating it with POS systems, enabling restaurants to manage all online orders on just oneeasy-to-use interface, easily add new apps and expand to new markets. | $150K / Seed / Aug 19, 2019 | |
Orbitless Drive
|
ORBITLESS™ is the first novel drivetrain technology in generations. The patent pending ORBITLESS™ Drive can be used in a variety of applications from Motion Control, Robotics, Electric vehicles, Wind Power or really anywhere gear motors are used . It can be an alternative to a Planetary Drives, Harmonic (strain-wave) or Spur Gearsets, or used incombination to derive the desired ideal gearbox. Available in single stage, multi-stage, high and low ratio configurations, the possibilities are endless. We work with leading innovative gearhead, power transmission, and gearmotor companies that are looking to maintain their competitive edge. Our company provides a technical consultancy service and a support network, to offer external clients transmission design, analysis, build and test engineering. | Seed / Feb 01, 2019 | |
Netskrt
|
Netskrt revolutionizes the Internet experience by extending the reach of internet video to the outskirts of the network. Traditionally, rail and air passengers have limited access to the internet content they want to watch. With the Netskrt mCDN, they can use their existing internet video subscriptions just like they do at home. | Angel / Jan 01, 2018 | |
SaNOtize
|
SaNOtize is a biotech company using a platform technology for topical to treat upper respiratory and dermal infections. The company develops a Nitric Oxide Releasing Solution platform technology to treat and prevent microbial infections, including drug resistant microbes. Its target indications include treatment for strep throat, athlete'sfoot, infected wounds, diabetic foot ulcers, sinusitis, cold and flu, and others.SaNOtize was founded in 2017 by Gilly Regev and Chris Miller and it is headquartered in Vancouver, British Columbia. | Angel / Jan 01, 2018 | |
CuePath Innovation
|
CuePath Innovation is a health tech company. They design medication packaging for seniors and provide a service that enables families to ensure that their senior family members stay on track with medications through mobile devices. They develop medication compliance monitoring products for clinical trials that dispense doses of tablets or capsulesin blister packaging. | $120K / Seed / Jan 26, 2017 | |
Microdermics
|
Microdermics is a Vancouver-based medical device company built on research at the University of British Columbia revolutionizing the biopharmaceutical market for both patients and healthcare practitioners. As the only company with a low-cost, scalable, hollow, metal microneedle, Microdermics eliminates the danger of accidental needle sticks causedby hypodermic needles and addresses the global health impact related to needle phobia. Microdermics will leverage its proprietary and innovative delivery system across a spectrum of biopharmaceuticals, including a new market for biosimilars, providing biopharmaceutical companies with a means of differentiating themselves from their competitors as well as securing product lifecycle extensions. | Seed / Jan 04, 2017 | |
Tuft + Paw
|
Tuft + Paw provides modern cat furniture designed to sleep, climb, scratch, play, and litter in. Its products are easy to assemble and machine washable. Founded in 2016, Tuft + Paw is based in Traverse City, Michigan. | $500K / Seed / Dec 05, 2016 | |
NZ Technologies
|
NZ Technologies is a technology company specializing in the design and manufacture of platform and products enable touchless interaction. | Angel / Jan 01, 2015 | |
Novelogics Biotechnology
|
They are a pre-clinical stage biotech company developing innovative antibody immunotherapies for cancer using a novel “Interceptor” approach. Our antibodies bind only to specific immunosuppressive proteins that are released from cancer cells (soluble ligands), and not to the cell surface-bound versions. This treatment is predicted to be effectivetowards multiple types of cancers and has safety built into the design of the drug, thereby minimizing the likelihood of unwanted side effects. Our current studies have demonstrated efficacy in repeated prostate cancer models in mice. | Angel / Jan 01, 2014 | |
| See all 15 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Angel Forum invest in?
Angel Forum invests primarily in Biotechnology, Health Care and Information Technology startups, most often at Seed and Angel stage. Most of the 15 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Angel Forum's check size?
Angel Forum typically joins rounds of $120k–$500k at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Angel Forum participates in.
How do I contact Angel Forum?
Public channels for Angel Forum include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Angel Forum?
The team at Angel Forum includes Bob Chaworth-Musters (Founder & Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
